Sign In
Buy INO
$1.14
-0.0700 (-5.79%)
At Close: Jun 03, 2026
Why Inovio Stock Is Jumping Today
11:23am, Friday, 27'th Nov 2020
No news was still good news for some investors.
4 Biotechs Likely to Gain on Coronavirus Vaccine Efforts
09:11am, Friday, 27'th Nov 2020
In the race to develop a coronavirus vaccine, Pfizer and its partner BioNTech have a lead, closely followed by Moderna. However, four other biotechs, NVAX, TBIO, INO and VXRT, still hold potential to
Is There Room for Latecomers to the COVID-19 Party?
07:28am, Saturday, 21'st Nov 2020
Despite multiple treatments, vaccines, and tests for COVID-19 developed by leading competitors, Sorrento's CEO Henry Ji thinks the company still has an opportunity to thrive.
Why Inovio Stock Slid Today
03:56pm, Friday, 20'th Nov 2020
Investors weren't impressed enough with the biotech's positive clinical data.
Is Inovio Back in the Coronavirus Vaccine Race?
08:08am, Friday, 20'th Nov 2020
The FDA has lifted a clinical hold on the biotech's phase 2 study, boosting its prospects for the future.
Inovio Gets the Go-Ahead But It's Probably Too Late
08:02am, Friday, 20'th Nov 2020
Inovio got the go-ahead from the FDA on Nov. 16 to resume its Phase 2 clinical trial. Is INO stock worth betting on this late in the game?
PLYMOUTH MEETING, Pa., Nov. 20, 2020 /PRNewswire/ -- INOVIO (NASDAQ: INO), a biotechnology company focused on rapidly bringing to market precisely designed DNA medicines to treat and protect people fr
Inovio: Accumulate For The HPV And Brain Cancer Therapies
11:10pm, Thursday, 19'th Nov 2020
First commercial approvals could be for HPV therapies in 2022. Brain cancer (glioblastoma) data could indicate a multibillion-dollar opportunity.
Inovio Pharmaceutical's FDA Plight Makes It a Highly Risky Bet
12:46pm, Wednesday, 18'th Nov 2020
INO stock has tumbled in the past few months. Inovio needs the FDA to bail it out by allowing the advanced trials of its vaccine to begin.
Inovio Analyst: COVID-19 Competition Could Be Too Great
05:41pm, Tuesday, 17'th Nov 2020
Inovio Pharmaceuticals Inc (NASDAQ: INO) reported Monday the lifting of the FDA-imposed partial clinical hold on the start of the Phase 2 study of INO-4800, its DNA coronavirus vaccine candidate. T
The Clock Is Ticking for Inovio Stock
01:58pm, Tuesday, 17'th Nov 2020
The FDA recently lifted the clinical hold on Inovio's Covid-19 vaccine candidate. The result could mean huge returns for INO stock.
Why Inovio Stock Plunged Today
01:55pm, Tuesday, 17'th Nov 2020
One analyst thinks you should sell the biotech's shares.
Inovio Has Little to Show for Its Covid-19 Efforts
11:53am, Tuesday, 17'th Nov 2020
Inovio Pharmaceuticals has little to show for its Covid-19 efforts. INO stock is not worth more than $2, according to one short-seller.
Could Inovio Pharmaceuticals Be a Millionaire-Maker Stock?
08:33am, Tuesday, 17'th Nov 2020
The popularity of coronavirus vaccine makers could blind investors to the risks of this investment.
Why Inovio Pharmaceuticals Stock Is Jumping Today
12:11pm, Monday, 16'th Nov 2020
The biotech delivered good news regarding its coronavirus vaccine program.
